We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lucigen Corporation and Research Corporation Technologies Announce Partnership

News   May 02, 2013

 
Lucigen Corporation and Research Corporation Technologies Announce Partnership
 
 
Advertisement
 

RELATED ARTICLES

RNA Key in Helping Stem Cells Know What To Become

News

New research concludes that RNA plays an indispensable role in cell differentiation, serving as a bridge between our genes and the epigenetic machinery that turns them on and off.

READ MORE

Structural Cells Multi-task To Engage in Immune Response

News

Analyzing epigenetic and transcriptional regulation in structural cells, researchers found widespread activity of immune genes, suggesting that structural cells are deeply involved in the body’s response to pathogens.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE